Wang, Yen-Feng
Yu, Chia-Chun
Kuan, Ai Seon
Chen, Shih-Pin
Wang, Shuu-Jiun http://orcid.org/0000-0001-5179-5358
Funding for this research was provided by:
Ministry of Science and Technology, Taiwan (MOST 109-2314-B-075 -054, MOST 108-2321-B-010-014 -MY2, 108-2321-B-010 001, 108-2314-B-010-023-MY3, and 110-2321-B-010-005)
Taipei Veterans General Hospital (VGH 108-C-092, VGH 109-C-096, and VGH 110-C-111)
National Yang-Ming University (Brain Research Center; The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE))
Article History
Received: 1 March 2021
Accepted: 16 April 2021
First Online: 10 May 2021
Declarations
:
: The study protocol was approved by the Institutional Review Board at the Taipei Veterans General Hospital (VGHTPE IRB No. 2018–07-020 BC, 2019–07-002CC). All participants provided informed consent prior to participation.
: Not applicable.
: YFW has received honoraria as a speaker from Taiwan branches of AbbVie, Eli Lilly, Novartis, Pfizer, Sanofi, and UCB. He has received research grants from the Taiwan Ministry of Science and Technology, and Taipei Veterans General Hospital. SJW has served on the advisory boards of Eli Lilly, Daiichi-Sankyo, and Taiwan Novartis. He has received honoraria as a moderator from Taiwan branches of AbbVie, Bayer, Eisai, Eli Lilly, and Pfizer. He has received research grants from the Taiwan Ministry of Science and Technology, National Yang-Ming University, Taipei Veterans General Hospital, Taiwan Headache Society, and Taiwan branches of Eli Lilly, Novartis, and Pfizer. CCY, ASK and SPC reported no disclosures relevant to the manuscript.